Harpoon Therapeutics Announces Acceptance of Five Abstracts
Preclinical abstracts for investigational T cell engagers, HPN328 and HPN217, in mouse models provide further
Globe Newswire15-03-2023, 05:27
Synaptics to Participate at Upcoming Investor Conferences 23-02-2023, 01:48